𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating

✍ Scribed by S. Greiner; A. Kadow-Romacker; G. Schmidmaier; B. Wildemann


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
222 KB
Volume
91A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The antiresorptive activity of bisphosphonates such as zoledronic acid (ZOL) has been shown in vitro to be because of their effect on osteoclasts and osteoblasts. However, whether the effect of ZOL on monocultures might be reproducible on cocultures and whether cell interactions might influence this effect has not been described. The aim of the study was to investigate the effect of ZOL on cocultures of osteoblasts and osteoclasts in vitro. ZOL was incorporated in an implant coating based on poly(D,L‐lactide) in different concentrations (10–50 μ__M__). Cell number was measured, and procollagen I synthesis, osteoprotegerin (OPG) secretion and soluble receptor activator of nuclear factor‐κB ligand (sRANKL) were analyzed. Moreover, TRAP‐positive cells and resorption lacunas on dentin chips were counted. Results showed that cell viability was not affected when treated with doses equivalent up to 50‐μ__M__ ZOL‐coated implants (ZOL‐CI). Procollagen I and OPG synthesis was highest when treated with 10 μ__M__ ZOL‐CI, whereas sRANKL showed no significant decrease when treated with the investigated concentrations of ZOL‐CI. TRAP‐positive cells were decreased when treated with ZOL‐CI in a dose‐dependent manner. Resorption activity of osteoclasts was not significantly decreased when treated with investigated concentrations of ZOL‐CI. Exposure to specific concentrations of ZOL‐CI showed a beneficial effect on osteoblast differentiation and protein synthesis. Formation of osteoclast was decreased, whereas a significant decrease in sRANKL secretion and resorption activity of osteoclasts could not be shown. The investigated effect on cocultures might be clinically useful to support fracture healing and to reduce orthopedic implant loosening. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009


📜 SIMILAR VOLUMES


The effect of zoledronic acid incorporat
✍ S. Greiner; A. Kadow-Romacker; M. Lübberstedt; G. Schmidmaier; B. Wildemann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 1 views

## Abstract Bisphosphonates such as zoledronic acid (ZOL) are used in diseases associated with osteoclast‐mediated bone loss. However, their antiresorptive activity is partly due to their effect on osteoblasts. Local application might increase the therapeutical fence and their local efficiency and